Terms: = Colorectal cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551
215 results:
1. Synthesis and characterisation of a nucleotide based pro-drug formulated with a peptide into a nano-chemotherapy for colorectal cancer.
Wilson JJ; Bennie L; Eguaogie O; Elkashif A; Conlon PF; Jena L; McErlean E; Buckley N; Englert K; Dunne NJ; Tucker JHR; Vyle JS; McCarthy HO
J Control Release; 2024 May; 369():63-74. PubMed ID: 38513729
[TBL] [Abstract] [Full Text] [Related]
2. Preventative strategies for low anterior resection syndrome.
Brock H; Lambrineas L; Ong HI; Chen WY; Das A; Edsell A; Proud D; Carrington E; Smart P; Mohan H; Burgess A
Tech Coloproctol; 2023 Dec; 28(1):10. PubMed ID: 38091118
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis.
Li R; Liu X; Huang X; Zhang D; Chen Z; Zhang J; Bai R; Zhang S; Zhao H; Xu Z; Zeng L; Zhuang L; Wen S; Wu S; Li M; Zuo Z; Lin J; Lin D; Zheng J
Gut; 2024 Feb; 73(3):470-484. PubMed ID: 38050068
[TBL] [Abstract] [Full Text] [Related]
4. A new, all-encompassing aetiology of type 1 diabetes.
de Groen PC
Immunology; 2024 Jan; 171(1):77-91. PubMed ID: 37772700
[TBL] [Abstract] [Full Text] [Related]
5. Effect of serum lactate dehydrogenase-to-albumin ratio (LAR) on the short-term outcomes and long-term prognosis of colorectal cancer after radical surgery.
Shu XP; Xiang YC; Liu F; Cheng Y; Zhang W; Peng D
BMC Cancer; 2023 Sep; 23(1):915. PubMed ID: 37770882
[TBL] [Abstract] [Full Text] [Related]
6. Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses.
Liu Y; Liang Y; Su Y; Hu J; Sun J; Zheng M; Huang Z
Comput Biol Med; 2023 Nov; 166():107432. PubMed ID: 37729701
[TBL] [Abstract] [Full Text] [Related]
7. Colonoscopy in the young: An indication-based analysis of outcome.
Abu Baker F; Samhat A; Taher Natour R; Zeina AR; Kopelman Y
J Investig Med; 2023 Dec; 71(8):797-803. PubMed ID: 37530168
[TBL] [Abstract] [Full Text] [Related]
8. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract] [Full Text] [Related]
9. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
[TBL] [Abstract] [Full Text] [Related]
10. Increased Proportion of colorectal cancer in Patients With Ulcerative Colitis Undergoing Surgery in the Netherlands.
Heuthorst L; Harbech H; Snijder HJ; Mookhoek A; D'Haens GR; Vermeire S; D'Hoore A; Bemelman WA; Buskens CJ
Am J Gastroenterol; 2023 May; 118(5):848-854. PubMed ID: 36623170
[TBL] [Abstract] [Full Text] [Related]
11. Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches.
Vale N; Pereira M; Santos J; Moura C; Marques L; Duarte D
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613510
[TBL] [Abstract] [Full Text] [Related]
12. [A Case of BRAF V600E-Mutant colorectal cancer Treated Effectively by Encorafenib, Binimetinib, and Cetuximab Triple Therapy].
Sakamoto S; Tagai N; Shimada M; Kurebayashi H; Sawai K; Morikawa M; Koneri K; Tamaki M; Murakami M; Hirono Y; Goi T
Gan To Kagaku Ryoho; 2022 Oct; 49(10):1145-1147. PubMed ID: 36281614
[TBL] [Abstract] [Full Text] [Related]
13. Hydrogen-bond-driven supramolecular helical assembly of a coumarin-substituted phthalonitrile derivative: synthesis and in vitro anticancer activity against colorectal adenocarcinoma.
Topkan F; Özdemir M; Özkan BN; Bozali K; Güler EM; Zorlu Y; Bulut M; Görgülü AO; Yalçın B
Acta Crystallogr D Struct Biol; 2022 Sep; 78(Pt 9):1143-1155. PubMed ID: 36048154
[TBL] [Abstract] [Full Text] [Related]
14. Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon cancer.
Lin H; Cao B
Dis Markers; 2022; 2022():3592990. PubMed ID: 35937946
[TBL] [Abstract] [Full Text] [Related]
15. MYC-Induced Upregulation of Lncrna ELFN1-AS1 Contributes to Tumor Growth in colorectal cancer via Epigenetically Silencing TPM1.
Li C; Hong S; Hu H; Liu T; Yan G; Sun D
Mol Cancer Res; 2022 Nov; 20(11):1697-1708. PubMed ID: 35857351
[TBL] [Abstract] [Full Text] [Related]
16. Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes.
Houvenaeghel G; de Nonneville A; Blache G; Buttarelli M; Jauffret C; Mokart D; Sabiani L
J Gynecol Oncol; 2022 May; 33(3):e31. PubMed ID: 35320883
[TBL] [Abstract] [Full Text] [Related]
17. Overexpression of GSTP1 promotes colorectal cancer cell proliferation, invasion and metastasis by upregulating STAT3.
Wang F; Zhang C; Zhu X; Zhang D; Zhang Z; Ni S; Wang Z; Xu S; Lan X; Ding Y; Liang L
Adv Clin Exp Med; 2022 Feb; 31(2):139-149. PubMed ID: 35195960
[TBL] [Abstract] [Full Text] [Related]
18. [A Case of Isolated Metachronous Splenic Metastasis after Rectal cancer Surgery].
Kuboyama Y; Sumi T; Sahara Y; Fukushima G; Matsumoto M; Matsudo T; Tachibana S; Mimuro H; Ishibashi Y; Katsumata K; Tsuchida A
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1688-1690. PubMed ID: 35046298
[TBL] [Abstract] [Full Text] [Related]
19. [A Case of Hyperammonemic Encephalopathy following mFOLFOX6 plus Panitumumab Therapy for Rectal cancer].
Tsujio G; Muguruma K; Eguchi S; Iseki Y; Miki Y; Yoshii M; Fukuoka T; Tamura T; Shibutani M; Nagahara H; Toyokawa T; Tanaka H; Lee S; Yashiro M; Ohira M
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2073-2075. PubMed ID: 35045497
[TBL] [Abstract] [Full Text] [Related]
20. S-Benzyl cysteine based cyclic dipeptide super hydrogelator: Enhancing efficacy of an anticancer drug via sustainable release.
Ghosh S; Nag S; Saha KD; Banerji B
J Pept Sci; 2022 Aug; 28(8):e3403. PubMed ID: 35001443
[TBL] [Abstract] [Full Text] [Related]
[Next]
